238 related articles for article (PubMed ID: 28830573)
1. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.
Korobeinikova E; Myrzaliyeva D; Ugenskiene R; Raulinaityte D; Gedminaite J; Smigelskas K; Juozaityte E
BMC Genet; 2015 Jun; 16():70. PubMed ID: 26112140
[TBL] [Abstract][Full Text] [Related]
3. Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancer.
Fu F; Guo W; Lin Y; Zeng B; Qiu W; Huang M; Wang C
J Transl Med; 2018 Oct; 16(1):270. PubMed ID: 30285756
[TBL] [Abstract][Full Text] [Related]
4. Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study.
Park HL; Ziogas A; Chang J; Desai B; Bessonova L; Garner C; Lee E; Neuhausen SL; Wang SS; Ma H; Clague J; Reynolds P; Lacey JV; Bernstein L; Anton-Culver H
BMC Cancer; 2016 Jan; 16():14. PubMed ID: 26758508
[TBL] [Abstract][Full Text] [Related]
5. Previous GWAS hits in relation to young-onset breast cancer.
Shi M; O'Brien KM; Sandler DP; Taylor JA; Zaykin DV; Weinberg CR
Breast Cancer Res Treat; 2017 Jan; 161(2):333-344. PubMed ID: 27848153
[TBL] [Abstract][Full Text] [Related]
6. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
[TBL] [Abstract][Full Text] [Related]
7. SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival.
Jamshidi M; Fagerholm R; Khan S; Aittomäki K; Czene K; Darabi H; Li J; Andrulis IL; Chang-Claude J; Devilee P; Fasching PA; Michailidou K; Bolla MK; Dennis J; Wang Q; Guo Q; Rhenius V; Cornelissen S; Rudolph A; Knight JA; Loehberg CR; Burwinkel B; Marme F; Hopper JL; Southey MC; Bojesen SE; Flyger H; Brenner H; Holleczek B; Margolin S; Mannermaa A; Kosma VM; ; Van Dyck L; Nevelsteen I; Couch FJ; Olson JE; Giles GG; McLean C; Haiman CA; Henderson BE; Winqvist R; Pylkäs K; Tollenaar RA; García-Closas M; Figueroa J; Hooning MJ; Martens JW; Cox A; Cross SS; Simard J; Dunning AM; Easton DF; Pharoah PD; Hall P; Blomqvist C; Schmidt MK; Nevanlinna H
Oncotarget; 2015 Nov; 6(35):37979-94. PubMed ID: 26317411
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.
Mavaddat N; Dunning AM; Ponder BA; Easton DF; Pharoah PD
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):255-9. PubMed ID: 19124506
[TBL] [Abstract][Full Text] [Related]
9. Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.
Rafiq S; Tapper W; Collins A; Khan S; Politopoulos I; Gerty S; Blomqvist C; Couch FJ; Nevanlinna H; Liu J; Eccles D
Cancer Res; 2013 Mar; 73(6):1883-91. PubMed ID: 23319801
[TBL] [Abstract][Full Text] [Related]
10. Common germline polymorphisms associated with breast cancer-specific survival.
Pirie A; Guo Q; Kraft P; Canisius S; Eccles DM; Rahman N; Nevanlinna H; Chen C; Khan S; Tyrer J; Bolla MK; Wang Q; Dennis J; Michailidou K; Lush M; Dunning AM; Shah M; Czene K; Darabi H; Eriksson M; Lambrechts D; Weltens C; Leunen K; van Ongeval C; Nordestgaard BG; Nielsen SF; Flyger H; Rudolph A; Seibold P; Flesch-Janys D; Blomqvist C; Aittomäki K; Fagerholm R; Muranen TA; Olsen JE; Hallberg E; Vachon C; Knight JA; Glendon G; Mulligan AM; Broeks A; Cornelissen S; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Cross SS; Reed MW; Giles GG; Milne RL; McLean C; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning MJ; Hollestelle A; Martens JW; van den Ouweland AM; Marme F; Schneeweiss A; Yang R; Burwinkel B; Figueroa J; Chanock SJ; Lissowska J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Brenner H; Butterbach K; Holleczek B; Kataja V; Kosma VM; Hartikainen JM; Li J; Brand JS; Humphreys K; Devilee P; Tollenaar RA; Seynaeve C; Radice P; Peterlongo P; Manoukian S; Ficarazzi F; Beckmann MW; Hein A; Ekici AB; Balleine R; Phillips KA; ; Benitez J; Zamora MP; Perez JI; Menéndez P; Jakubowska A; Lubinski J; Gronwald J; Durda K; Hamann U; Kabisch M; Ulmer HU; Rüdiger T; Margolin S; Kristensen V; Nord S; ; Evans DG; Abraham J; Earl H; Poole CJ; Hiller L; Dunn JA; Bowden S; Yang R; Campa D; Diver WR; Gapstur SM; Gaudet MM; Hankinson S; Hoover RN; Hüsing A; Kaaks R; Machiela MJ; Willett W; Barrdahl M; Canzian F; Chin SF; Caldas C; Hunter DJ; Lindstrom S; Garcia-Closas M; Couch FJ; Chenevix-Trench G; Mannermaa A; Andrulis IL; Hall P; Chang-Claude J; Easton DF; Bojesen SE; Cox A; Fasching PA; Pharoah PD; Schmidt MK
Breast Cancer Res; 2015 Apr; 17(1):58. PubMed ID: 25897948
[TBL] [Abstract][Full Text] [Related]
11. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.
Fagerholm R; Khan S; Schmidt MK; García-Closas M; Heikkilä P; Saarela J; Beesley J; Jamshidi M; Aittomäki K; Liu J; Ali HR; Andrulis IL; Beckmann MW; Behrens S; Blows FM; Brenner H; Chang-Claude J; Couch FJ; Czene K; Fasching PA; Figueroa J; Floris G; Glendon G; Guo Q; Hall P; Hallberg E; Hamann U; Holleczek B; Hooning MJ; Hopper JL; Jager A; Kabisch M; ; Keeman R; Kosma VM; Lambrechts D; Lindblom A; Mannermaa A; Margolin S; Provenzano E; Shah M; Southey MC; Dennis J; Lush M; Michailidou K; Wang Q; Bolla MK; Dunning AM; Easton DF; Pharoah PD; Chenevix-Trench G; Blomqvist C; Nevanlinna H
Oncotarget; 2017 Mar; 8(11):18381-18398. PubMed ID: 28179588
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide association study of prognosis in breast cancer.
Azzato EM; Pharoah PD; Harrington P; Easton DF; Greenberg D; Caporaso NE; Chanock SJ; Hoover RN; Thomas G; Hunter DJ; Kraft P
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1140-3. PubMed ID: 20332263
[TBL] [Abstract][Full Text] [Related]
13. Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity.
Dorling L; Barnett GC; Michailidou K; Coles CE; Burnet NG; Yarnold J; Elliott RM; Dunning AM; Pharoah PD; West CM
Clin Cancer Res; 2016 Mar; 22(6):1413-20. PubMed ID: 26510858
[TBL] [Abstract][Full Text] [Related]
14. Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.
Barrdahl M; Canzian F; Joshi AD; Travis RC; Chang-Claude J; Auer PL; Gapstur SM; Gaudet M; Diver WR; Henderson BE; Haiman CA; Schumacher FR; Le Marchand L; Berg CD; Chanock SJ; Hoover RN; Rudolph A; Ziegler RG; Giles GG; Baglietto L; Severi G; Hankinson SE; Lindström S; Willet W; Hunter DJ; Buring JE; Lee IM; Zhang S; Dossus L; Cox DG; Khaw KT; Lund E; Naccarati A; Peeters PH; Quirós JR; Riboli E; Sund M; Trichopoulos D; Prentice RL; Kraft P; Kaaks R; Campa D
Hum Mol Genet; 2014 Oct; 23(19):5260-70. PubMed ID: 24895409
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort.
Goh CL; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Thomas K; Selvadurai ED; Woode-Amissah R; Dadaev T; Mahmud N; Castro E; Olmos D; Guy M; Govindasami K; O'Brien LT; Hall AL; Wilkinson RA; Sawyer EJ; Al Olama AA; Easton DF; Kote-Jarai Z; Parker CC; Eeles RA
BJU Int; 2013 Sep; 112(5):666-73. PubMed ID: 23320731
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel genetic markers of breast cancer survival.
Guo Q; Schmidt MK; Kraft P; Canisius S; Chen C; Khan S; Tyrer J; Bolla MK; Wang Q; Dennis J; Michailidou K; Lush M; Kar S; Beesley J; Dunning AM; Shah M; Czene K; Darabi H; Eriksson M; Lambrechts D; Weltens C; Leunen K; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Blomqvist C; Aittomäki K; Fagerholm R; Muranen TA; Couch FJ; Olson JE; Vachon C; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Broeks A; Hogervorst FB; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Cox A; Cross SS; Reed MW; Giles GG; Milne RL; McLean C; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning MJ; Hollestelle A; Martens JW; van den Ouweland AM; Marme F; Schneeweiss A; Yang R; Burwinkel B; Figueroa J; Chanock SJ; Lissowska J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Brenner H; Dieffenbach AK; Arndt V; Holleczek B; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Li J; Brand JS; Humphreys K; Devilee P; Tollenaar RA; Seynaeve C; Radice P; Peterlongo P; Bonanni B; Mariani P; Fasching PA; Beckmann MW; Hein A; Ekici AB; Chenevix-Trench G; Balleine R; ; Phillips KA; Benitez J; Zamora MP; Arias Perez JI; Menéndez P; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Hamann U; Kabisch M; Ulmer HU; Rüdiger T; Margolin S; Kristensen V; Nord S; Evans DG; Abraham JE; Earl HM; Hiller L; Dunn JA; Bowden S; Berg C; Campa D; Diver WR; Gapstur SM; Gaudet MM; Hankinson SE; Hoover RN; Hüsing A; Kaaks R; Machiela MJ; Willett W; Barrdahl M; Canzian F; Chin SF; Caldas C; Hunter DJ; Lindstrom S; García-Closas M; Hall P; Easton DF; Eccles DM; Rahman N; Nevanlinna H; Pharoah PD
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25890600
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variants in Metabolic Signaling Pathways and Their Interaction with Lifestyle Factors on Breast Cancer Risk: A Random Survival Forest Analysis.
Jung SY; Papp JC; Sobel EM; Zhang ZF
Cancer Prev Res (Phila); 2018 Jan; 11(1):44-51. PubMed ID: 29074537
[TBL] [Abstract][Full Text] [Related]
18. The Associations of Common Genetic Susceptibility Variants with Breast Cancer in Jordanian Arabs: A Case-Control Study.
Al-Eitan LN; M Rababa'h D; Aman HA
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3045-3054. PubMed ID: 33112566
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study.
Lee E; Takita C; Wright JL; Slifer SH; Martin ER; Urbanic JJ; Langefeld CD; Lesser GJ; Shaw EG; Hu JJ
Hum Genomics; 2019 Jun; 13(1):28. PubMed ID: 31196165
[TBL] [Abstract][Full Text] [Related]
20. A 23 gene-based molecular prognostic score precisely predicts overall survival of breast cancer patients.
Shimizu H; Nakayama KI
EBioMedicine; 2019 Aug; 46():150-159. PubMed ID: 31358476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
